{"id":207431,"name":"AMNEAL","slug":"amneal","state":"NJ","country":"United States of America","description":"Generic drug issues.","totalSpending":340000,"filings":7,"yearlySpending":[{"year":2020,"income":60000},{"year":2021,"income":240000},{"year":2022,"income":40000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"},{"code":"MAN","display":"Manufacturing"}],"firms":["MEHLMAN CONSULTING, INC."],"lobbyists":["DEAN ROSEN","DAVID THOMAS","ELISE FINLEY PICKERING","DAVID CASTAGNETTI","BRUCE MEHLMAN","STEVE HARO","SAGE EASTMAN","LAUREN ARONSON","MICHAEL ROBINSON","CONSTANTINE HINGSON","HELEN TOLAR","NICHOLE DISTEFANO","MCKENZIE BRICE","PAUL THORNELL","STEPHEN COTE","ALEXANDER PERKINS","VICTORIA FLOOD","ROSEMARY GUTIERREZ","ZACHARY MALLOVE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","White House Office"],"sampleDescriptions":["Generic drug issues.","Generic drug issues.","Monitoring legislative and regulatory efforts related to domestic manufacturing of generic drugs.","Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs.","Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs."]}